CD274 and pancreatic ductal adenocarcinoma: Research has shown that Chimeric Vaccinia Virus CF33 expressing anti-PD-L1 antibody can infect pancreatic ductal adenocarcinoma cells, producing anti-PD-L1 antibodies, effectively blocking the action of PD-L1 on the surface of tumor cells, leading to the enhanced anti-tumor immune killing [59].